AtriCure, Inc.
ATRC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 16.5% | 20.8% | 20.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 74.7% | 75.2% | 74.4% | 75% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -4% | -2% | -8.9% | 24% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -9.6% | -7.6% | -14.1% | 18.3% |
| EPS Diluted | -0.95 | -0.66 | -1.02 | 1.09 |
| % Growth | -43.9% | 35.3% | -193.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |